Estimaciones de analistas de Wall Street para Oragenics, Inc. (OGEN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 0.61 |
| EV / EBITDA | 0.22 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $75044 | $65803 | $30110 | $62622 | $22.1M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$75044 | -$65803 | -$30110 | -$62622 | -$22.1M | 0 | 0 | 0 | 0 | 0 |
| I+D | $4.8M | $3.5M | $6.0M | $12.1M | $22.1M | $10.6M | $10.1M | $15.5M | $4.1M | $2.39B |
| Generales y Administrativos | $3.8M | $3.2M | $4.0M | $3.8M | $4.5M | $5.3M | $4.5M | $5.5M | $6.4M | $6.97B |
| Gastos Operativos | $8.5M | $6.7M | $10.0M | $15.9M | $4.5M | $15.8M | $14.4M | $20.9M | $10.6M | $9.4M |
| Beneficio Operativo | -$8.5M | -$6.7M | -$10.0M | -$15.9M | -$26.6M | -$15.8M | -$14.4M | -$20.9M | -$10.6M | -$9.4M |
| EBITDA | -$8.4M | -$6.4M | -$9.9M | -$15.5M | -$26.6M | -$15.7M | -$14.2M | -$20.6M | -$10.5M | $762.2M |
| Gastos por Intereses | $4116 | $216328 | $5786 | $7300 | $10685 | $15756 | $15103 | $30591 | $29828 | $785930 |
| Beneficio Antes de Impuestos | -$8.5M | -$6.7M | -$9.9M | -$15.6M | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$10.0M |
| Impuestos | 0 | $13207 | -$79999 | $7756 | 0 | 0 | 0 | 0 | 0 | -$136910 |
| Beneficio Neto | -$7.0M | -$6.7M | -$9.9M | -$15.6M | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$9.8M |
| BPA | $-94.35 | $-81.99 | $-45.62 | $-22.10 | $-28.05 | $-8.09 | $-7.11 | $-9.18 | $-1.60 | $-4.56 |
| BPA Diluido | $-94.33 | $-81.99 | $-45.62 | $-22.10 | $-28.05 | $-8.09 | $-7.11 | $-9.18 | $-1.60 | $-4.56 |
| Acciones en Circulación (Diluidas) | $74348 | $82104 | $217318 | $704732 | $942187 | $1.9M | $2.0M | $2.2M | $6.6M | $2.2M |
Precio
| Precio | $0.50 |
| Capitalización | $2M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: AIM · CANF · CNSP · ENSC · KALA · KZIA · QLGN
Explorar sector: Healthcare · Biotechnology
Más secciones de OGEN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones